ストックスクリーナーアプリを入手
1.86
0.53%
-0.01
アフターアワーズ：
1.75
-0.11
-5.91%
前日終値:
$1.87
開ける：
$1.9
24時間の取引高:
202.34K
Relative Volume:
0.66
時価総額：
$13.09M
収益：
-
当期純損益:
$-7.72M
株価収益率:
-0.7047
EPS:
-2.6394
ネットキャッシュフロー:
$-6.25M
1週間 パフォーマンス:
-32.12%
1か月 パフォーマンス:
-24.70%
6か月 パフォーマンス:
-20.17%
1年 パフォーマンス:
-43.64%
1日の値動き範囲:
$1.75
$1.96
1週間の範囲:
$1.75
$2.69
52週間の値動き範囲:
$1.55
$4.4899
Edesa Biotech Inc Stock (EDSA) Company Profile
EDSA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
EDSA
Edesa Biotech Inc
|
1.86 | 13.73M | 0 | -7.72M | -6.25M | -2.6394 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Edesa Biotech Inc (EDSA) 最新ニュース
Best data tools to analyze Edesa Biotech Inc. stock2025 Trading Volume Trends & Expert Curated Trade Setup Alerts - newser.com
Is Edesa Biotech Inc. stock affected by interest rate hikes2025 Year in Review & Weekly Top Gainers Alerts - newser.com
Edesa Biotech Inc. (EDSA) Stock Price | Live Quotes & Charts | NSC - StocksToTrade
Edesa Biotech to Participate in Key Industry Conferences - TipRanks
Edesa Biotech Announces Upcoming Conference Schedule - The Manila Times
Edesa Biotech (NASDAQ: EDSA) to attend BIO-Europe Vienna, LSX London in November 2025 - Stock Titan
Favourable Signals For Edesa Biotech: Numerous Insiders Acquired Stock - simplywall.st
Is Edesa Biotech Inc. still worth holding after the dipMarket Trend Review & Technical Buy Zone Confirmations - newser.com
Will Edesa Biotech Inc. stock benefit from sector rotationQuarterly Risk Review & Free Weekly Chart Analysis and Trade Guides - newser.com
Has Edesa Biotech Inc. found a price floor2025 Sector Review & Precise Swing Trade Alerts - newser.com
Is Edesa Biotech Inc a good long term investmentMean Reversion Trades & Affordable Trading Portfolio - earlytimes.in
EDSA’s Market Surge: Time to Jump In? - StocksToTrade
Edesa’s ARDS drug shows 25% reduction in death risk in phase 3 trial By Investing.com - Investing.com South Africa
Edesa’s ARDS drug shows 25% reduction in death risk in phase 3 trial - Investing.com India
EDSA’s Performance: What’s Driving the Change? - timothysykes.com
Edesa Biotech Reports Positive Phase 3 Results For Paridiprubart In ARDS - Nasdaq
Edesa Biotech reports positive Phase 3 results for ARDS drug candidate - Investing.com Nigeria
Edesa Biotech Announces Positive Phase 3 Study Results - TipRanks
Edesa Biotech Announces Positive Phase 3 Results for ARDS Treatment - TradingView
Edesa Biotech Announces Positive Phase 3 Results for Paridiprubart in Treating Acute Respiratory Distress Syndrome, Showing Significant Reduction in Mortality - Quiver Quantitative
Edesa Biotech Reports Positive Results in Phase 3 Respiratory Study - GlobeNewswire
Pigmentation Disorders Treatment Market Is Booming Worldwide 2025-2032 |Abbvie Inc., Edesa Biotech, Inc., Amgen - openPR.com
Is Edesa Biotech Inc. stock resilient to inflationMarket Performance Recap & Capital Efficiency Focused Ideas - newser.com
Sentiment analysis tools applied to Edesa Biotech Inc.2025 Sector Review & Community Shared Stock Ideas - newser.com
How to use a screener to detect Edesa Biotech Inc. breakoutsQuarterly Market Summary & Precise Trade Entry Recommendations - newser.com
Edesa Biotech Inc (EDSA) 財務データ
収益
当期純利益
現金流量
EPS
1.62%
0.21%
大文字化:
|
ボリューム (24 時間):